iTonic Holdings Ltd (ITOC) research

iTonic Holdings Ltd
ShareXLinkedInReddit
Sector
Healthcare
Industry
Medical Devices
Last price
$0.32
As of

iTonic Holdings Ltd (ITOC): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-10.

As of . Source: SEC EDGAR filings for ITOC. Method and limitations.

SHARE THIS CARD

Share the ITOC intelligence card

A branded snapshot of ITOC: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion ITOC intelligence card preview
Post to X
LIVE TERMINAL

See ITOC live in the terminal

Track ITOC's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live ITOC terminal, free

Active signals for ITOC

FREE, NO ACCOUNT

Every signal on ITOC, as it fires

You are seeing 5 of 7 signals recorded on ITOC since 2026-08-16.

The five above landed across 2 days. The other 2 were recorded on those same days. 7 of the 7 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in ITOC (2026Q2)

Manager / securityMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP G71399102 · 2026Q2$13K0.00%,
CITADEL ADVISORS LLCCUSIP G71399102 · 2026Q2$13K0.00%,
Point72 Asset Management, L.P.CUSIP G71399102 · 2026Q2$3K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, ITOC

ITOC against its peers

ITOC's operating margin of -991.7% ranks in the 34th percentile of 15 Medical Devices sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.

MetricITOCPeer medianPercentilen
Revenue FY523031 USD3.3M USD2517
Revenue YoY16.7%-15.3%936
Gross margin62.6%44.6%7714
Operating margin-991.7%-324.3%3415
Net margin-974.7%-306.6%3216
Return on equity-83.3%-219.4%7215

Peers (19): USAQ, STME, VNRX, INBS, NVNO, AMIX, NXL, TNON, AIDX, VVOS, ICCM, CODX, ADMT, WOK, RMSL, XAIR, POAS, BMRA, NUWE. Left out: CYDX (no annual filing), SONX (period gap), TRIB (period gap), KLYG (no annual filing), PMEDF (period gap), CSDX (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (ITOC: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more ITOC signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ITOCand get the insider, 13F, options, and confluence read in one view.

Open the live ITOC terminal, free